In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.
Jul 15, 2021•16 min•Season 2Ep. 6
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
Jun 15, 2021•33 min•Season 2Ep. 5
In season 2, episode 4 of Targeted Talks, Benjamin O. Anderson, MD, FACS, discussed the lessons learned from the COVID-19 pandemic, and preparation for a post-COVID America.
May 14, 2021•9 min•Season 2Ep. 4
Jason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.
Apr 15, 2021•29 min•Season 2Ep. 3
Cathy Eng, MD and Benjamin Weinberg, MD discuss the gut microbiome and how it impacts young patients with colorectal. They also discuss the potential to use gut microbiome test to inform diagnosis, treatment, and monitoring of patients.
Feb 15, 2021•33 min•Season 2Ep. 2
Nagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.
Jan 15, 2021•28 min•Season 2Ep. 1
Debra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States
Dec 17, 2020•26 min•Season 1Ep. 5
In season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, associate professor. Clinical Research Division, Fred Hutchinson Cancer Research Center, spoke with fellow oncologist, Winston Tan, MD, medical oncologist and professor of medicine, Mayo Clinic, about the ever-changing treatment landscape for prostate cancer.
Oct 15, 2020•24 min•Season 1Ep. 4
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion with Stephanie Graff, MD, and Gabriel N. Hortobagyi, MD, FACP.
Sep 25, 2020•28 min•Season 1Ep. 3
Sarah M. Temkin, MD leads a discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.
Jul 15, 2020•39 min•Season 1Ep. 2
A discussion on immunotherapy use in non–small cell lung cancer between community physician Jason William, MD, DABR and research physician George R. Simon, MD, FACP, FCCP.
Jun 15, 2020•37 min•Season 1Ep. 1
